[
  {
    "ts": "2025-11-13T01:27:00+00:00",
    "headline": "3 Healthcare Stocks Topping a 2025 List of Dividend Yields",
    "summary": "Turn health into wealth with these three high-yielding dividend stocks.",
    "url": "https://www.fool.com/investing/2025/11/12/3-healthcare-stocks-topping-a-2025-list-of-dividen/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "fa15a7d6-932b-30e4-9233-4ce308ec27b2",
      "content": {
        "id": "fa15a7d6-932b-30e4-9233-4ce308ec27b2",
        "contentType": "STORY",
        "title": "3 Healthcare Stocks Topping a 2025 List of Dividend Yields",
        "description": "",
        "summary": "Turn health into wealth with these three high-yielding dividend stocks.",
        "pubDate": "2025-11-13T01:27:00Z",
        "displayTime": "2025-11-13T01:27:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/1e0f427fa53007e24b9457b0c759b3e6",
          "originalWidth": 1400,
          "originalHeight": 937,
          "caption": "A stethoscope sits atop $100 bills laid out on a table.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XgrBi89kZjh6dZFYMGo5OA--~B/aD05Mzc7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/1e0f427fa53007e24b9457b0c759b3e6.cf.webp",
              "width": 1400,
              "height": 937,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hHoMDrSXZL5QAlzVYfaoQw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/1e0f427fa53007e24b9457b0c759b3e6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/12/3-healthcare-stocks-topping-a-2025-list-of-dividen/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-healthcare-stocks-topping-2025-012700712.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "XRAY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T09:55:00+00:00",
    "headline": "Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?",
    "summary": "Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock.",
    "url": "https://www.fool.com/investing/2025/11/13/forget-pfizer-buy-magnificent-drug-stock/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "ddac82d5-7cca-3ff5-bd66-72b1c4d36c5b",
      "content": {
        "id": "ddac82d5-7cca-3ff5-bd66-72b1c4d36c5b",
        "contentType": "STORY",
        "title": "Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?",
        "description": "",
        "summary": "Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock.",
        "pubDate": "2025-11-13T09:55:00Z",
        "displayTime": "2025-11-13T09:55:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/3a48e52c797c1a215add24a2a50cd8a6",
          "originalWidth": 1199,
          "originalHeight": 711,
          "caption": "A person with their hands up in frustration.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bPKERggN_Ctl_MGeOY3Myw--~B/aD03MTE7dz0xMTk5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/3a48e52c797c1a215add24a2a50cd8a6.cf.webp",
              "width": 1199,
              "height": 711,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WYbca0fos3_KTGz6FtsqlA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/3a48e52c797c1a215add24a2a50cd8a6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/13/forget-pfizer-buy-magnificent-drug-stock/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/forget-pfizer-buy-magnificent-drug-095500549.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T12:01:09+00:00",
    "headline": "Inside Yahoo Finance Invest 2025: Elon Musk's $1 trillion pay package, crypto cracks, and AI bubbles",
    "summary": "If you love investing or want to love investing, Yahoo Finance's annual Invest event is here to help!",
    "url": "https://finance.yahoo.com/news/inside-yahoo-finance-invest-2025-elon-musks-1-trillion-pay-package-crypto-cracks-and-ai-bubbles-120109950.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "d4716c13-ca1e-48f5-bd3e-7150c75c0270",
      "content": {
        "id": "d4716c13-ca1e-48f5-bd3e-7150c75c0270",
        "contentType": "STORY",
        "title": "Inside Yahoo Finance Invest 2025: Elon Musk's $1 trillion pay package, crypto cracks, and AI bubbles",
        "description": "",
        "summary": "If you love investing or want to love investing, Yahoo Finance's annual Invest event is here to help!",
        "pubDate": "2025-11-13T12:01:09Z",
        "displayTime": "2025-11-13T12:01:09Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-10/1fd2a390-a93e-11f0-af7b-3a2e18b77fcc",
          "originalWidth": 561,
          "originalHeight": 316,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6K.EleSfORqVAvfPmbIgoQ--~B/aD0zMTY7dz01NjE7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-10/1fd2a390-a93e-11f0-af7b-3a2e18b77fcc.cf.webp",
              "width": 561,
              "height": 316,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PuXVQ74oon_G1bzkXESUUg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-10/1fd2a390-a93e-11f0-af7b-3a2e18b77fcc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/inside-yahoo-finance-invest-2025-elon-musks-1-trillion-pay-package-crypto-cracks-and-ai-bubbles-120109950.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/inside-yahoo-finance-invest-2025-elon-musks-1-trillion-pay-package-crypto-cracks-and-ai-bubbles-120109950.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "HUT"
            },
            {
              "symbol": "MSTR"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "ABTC"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "DAL"
            },
            {
              "symbol": "ETOR"
            },
            {
              "symbol": "TFC"
            },
            {
              "symbol": "COIN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T11:50:00+00:00",
    "headline": "Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results",
    "summary": "Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today reported financial results for the quarter ended September 30, 2025, and provided a financial and business update.",
    "url": "https://finance.yahoo.com/news/protalix-biotherapeutics-reports-third-quarter-115000712.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "4c30cf0a-d188-3a3c-95d4-cb81b34806ea",
      "content": {
        "id": "4c30cf0a-d188-3a3c-95d4-cb81b34806ea",
        "contentType": "STORY",
        "title": "Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results",
        "description": "",
        "summary": "Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today reported financial results for the quarter ended September 30, 2025, and provided a financial and business update.",
        "pubDate": "2025-11-13T11:50:00Z",
        "displayTime": "2025-11-13T11:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/f2174d5c59bc5e34e9e5ea6a94c7eeba",
          "originalWidth": 400,
          "originalHeight": 121,
          "caption": "Protalix Biotherapeutics Logo (PRNewsfoto/Protalix Biotherapeutics Inc)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gKHaK2aaXdNF9jevNdwC4A--~B/aD0xMjE7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f2174d5c59bc5e34e9e5ea6a94c7eeba.cf.webp",
              "width": 400,
              "height": 121,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a9XClvTONPq7IISlgdiW6A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f2174d5c59bc5e34e9e5ea6a94c7eeba.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/protalix-biotherapeutics-reports-third-quarter-115000712.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/protalix-biotherapeutics-reports-third-quarter-115000712.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLX"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T11:23:07+00:00",
    "headline": "CPHI 2025: ‘handprint’ metric bridges pharma sustainability and economic value",
    "summary": "The WifOR Institute’s ‘handprint’ quantifies positive socioeconomic impact of pharma products, positing a sustainability metric.",
    "url": "https://www.pharmaceutical-technology.com/news/cphi-2025-handprint-metric-bridges-pharma-sustainability-and-economic-value/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "4573853d-fedb-3c4a-affa-9b7b6d701c92",
      "content": {
        "id": "4573853d-fedb-3c4a-affa-9b7b6d701c92",
        "contentType": "STORY",
        "title": "CPHI 2025: ‘handprint’ metric bridges pharma sustainability and economic value",
        "description": "",
        "summary": "The WifOR Institute’s ‘handprint’ quantifies positive socioeconomic impact of pharma products, positing a sustainability metric.",
        "pubDate": "2025-11-13T11:23:07Z",
        "displayTime": "2025-11-13T11:23:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/e738fb73327688d20bef46b07d155b2a",
          "originalWidth": 1440,
          "originalHeight": 810,
          "caption": "The WifOR Institute’s ‘handprint’ metric has been used by pharma supplier Evonik to assess the broader socioeconomic impact of their PhytoChol vaccine product. Credit: Photo by wh1600 / E+ via Getty Images.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qgd2Wv4I.79_gZ7_7jjQyw--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/e738fb73327688d20bef46b07d155b2a.cf.webp",
              "width": 1440,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IMnZ6rFZ1xbron68Qp1Asg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/e738fb73327688d20bef46b07d155b2a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/cphi-2025-handprint-metric-bridges-pharma-sustainability-and-economic-value/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cphi-2025-handprint-metric-bridges-112307936.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BNTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T14:45:38+00:00",
    "headline": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
    "summary": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
    "url": "https://finance.yahoo.com/news/nike-upgraded-dollar-tree-downgraded-144538422.html",
    "source": "The Fly",
    "provider": "yfinance",
    "raw": {
      "id": "8797ed93-cd75-34fe-b872-cf042d802372",
      "content": {
        "id": "8797ed93-cd75-34fe-b872-cf042d802372",
        "contentType": "STORY",
        "title": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
        "description": "",
        "summary": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
        "pubDate": "2025-11-13T14:45:38Z",
        "displayTime": "2025-11-13T14:45:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec",
          "originalWidth": 1200,
          "originalHeight": 628,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YHTvjvqtNAYBPYViMXYCow--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 1200,
              "height": 628,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J3gfZRz3Jb2im4_aLYVn4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Fly",
          "url": "https://thefly.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nike-upgraded-dollar-tree-downgraded-144538422.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nike-upgraded-dollar-tree-downgraded-144538422.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DASH"
            },
            {
              "symbol": "SSTI"
            },
            {
              "symbol": "CRCL"
            },
            {
              "symbol": "NKE"
            },
            {
              "symbol": "KRRO"
            },
            {
              "symbol": "DLTR"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "COO"
            },
            {
              "symbol": "BKNG"
            },
            {
              "symbol": "AZO"
            },
            {
              "symbol": "LWAY"
            },
            {
              "symbol": "FAST"
            },
            {
              "symbol": "VITL"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "RKT"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T17:14:56+00:00",
    "headline": "Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects company's 'right to win' obesity market",
    "summary": "Pfizer CEO Albert Bourla told Yahoo Finance that Pfizer has a \"right to win\" on the obesity drugs that have become a major market.",
    "url": "https://finance.yahoo.com/news/pfizer-ceo-albert-bourla-says-aggressive-bid-for-metsera-reflects-companys-right-to-win-obesity-market-171456959.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "4eb6f877-7591-4d46-a874-6608e9923dde",
      "content": {
        "id": "4eb6f877-7591-4d46-a874-6608e9923dde",
        "contentType": "STORY",
        "title": "Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects company's 'right to win' obesity market",
        "description": "",
        "summary": "Pfizer CEO Albert Bourla told Yahoo Finance that Pfizer has a \"right to win\" on the obesity drugs that have become a major market.",
        "pubDate": "2025-11-13T17:14:56Z",
        "displayTime": "2025-11-13T17:14:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/d07cbc50-c08e-11f0-bb77-ee97f9f46288",
          "originalWidth": 5327,
          "originalHeight": 3551,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5QHKyc4nETYI_CKxDSpDKw--~B/aD0zNTUxO3c9NTMyNzthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/d07cbc50-c08e-11f0-bb77-ee97f9f46288.cf.webp",
              "width": 5327,
              "height": 3551,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IidjbYJIrf4G8eG3NbnszQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/d07cbc50-c08e-11f0-bb77-ee97f9f46288.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-ceo-albert-bourla-says-aggressive-bid-for-metsera-reflects-companys-right-to-win-obesity-market-171456959.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-ceo-albert-bourla-says-aggressive-bid-for-metsera-reflects-companys-right-to-win-obesity-market-171456959.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "AZN.L"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T16:26:00+00:00",
    "headline": "Pfizer Completes Acquisition of Metsera",
    "summary": "NEW YORK, November 13, 2025--Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases.",
    "url": "https://finance.yahoo.com/news/pfizer-completes-acquisition-metsera-162600502.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "1853cc2b-72fe-3423-9b10-a2657b61e193",
      "content": {
        "id": "1853cc2b-72fe-3423-9b10-a2657b61e193",
        "contentType": "STORY",
        "title": "Pfizer Completes Acquisition of Metsera",
        "description": "",
        "summary": "NEW YORK, November 13, 2025--Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases.",
        "pubDate": "2025-11-13T16:26:00Z",
        "displayTime": "2025-11-13T16:26:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/642df4c0df76d58d09ad907959e705a1",
          "originalWidth": 480,
          "originalHeight": 212,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7sfuJT6vjIQAgxGEBIaVlg--~B/aD0yMTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/642df4c0df76d58d09ad907959e705a1.cf.webp",
              "width": 480,
              "height": 212,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6AvFZcgeCYdeRdbWl1S1qQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/642df4c0df76d58d09ad907959e705a1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-completes-acquisition-metsera-162600502.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-completes-acquisition-metsera-162600502.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]